Log in to save to my catalogue

Attenuated androgen discontinuation in patients with hereditary angioedema: a commented case series

Attenuated androgen discontinuation in patients with hereditary angioedema: a commented case series

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_5c2ad1d8ea544b7b9d2fa3693dc729cb

Attenuated androgen discontinuation in patients with hereditary angioedema: a commented case series

About this item

Full title

Attenuated androgen discontinuation in patients with hereditary angioedema: a commented case series

Publisher

England: BioMed Central Ltd

Journal title

Allergy, asthma, and clinical immunology, 2022-01, Vol.18 (1), p.4-4, Article 4

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Hereditary angioedema (HAE) is characterized by potentially severe and life-threatening attacks of localized swelling. Prophylactic therapies are available, including attenuated androgens. Efficacy of attenuated androgens has not been assessed in large, randomized, placebo-controlled trials and can be associated with frequent, and sometimes severe,...

Alternative Titles

Full title

Attenuated androgen discontinuation in patients with hereditary angioedema: a commented case series

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_5c2ad1d8ea544b7b9d2fa3693dc729cb

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_5c2ad1d8ea544b7b9d2fa3693dc729cb

Other Identifiers

ISSN

1710-1484,1710-1492

E-ISSN

1710-1492

DOI

10.1186/s13223-021-00644-0

How to access this item